Successful endovascular treatment of abdominal aortic rupture secondary to bacillus Calmette-Guérin vaccine.

Publication Title

J Vasc Surg Cases Innov Tech

Authors

Andrew E Liechty
Albert Pacifico, Division of Medicine, Section of Infectious Diseases, Providence Regional Medical Center Everett, Everett, WA, USAFollow
Peter Brant-Zawadzki, Division of Medicine, Section of Infectious Diseases, Providence Regional Medical Center Everett, Everett, WA, USAFollow

Document Type

Article

Publication Date

3-1-2022

Keywords

washington; everett; BCG vaccine; EVAR treatment; Infected graft; Mycotic pseudoaneurysm; Prophylaxis

Abstract

Bacillus Calmette-Guérin (BCG) vaccine has been successfully used to treat bladder cancer. However, sporadic cases of mycotic arterial aneurysms have been reported. These patients typically develop a Mycobacterium bovis infection of an existing aneurysm or graft. In the present report, we have described the case of a patient with a ruptured nonaneurysmal abdominal aorta years after intravesicular BCG therapy. Emergent aortic endograft repair was successful. After subsequent evaluation confirmed M. bovis infection, the patient was treated with a prolonged course of antimycobacterial therapy. Vascular surgeons should maintain suspicion for atypical aortic ruptures in patients with exposure to intravesicular BCG therapy.

Clinical Institute

Cancer

Clinical Institute

Cardiovascular (Heart)

Specialty/Research Institute

Oncology

Specialty/Research Institute

Cardiology

Specialty/Research Institute

Surgery